• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuropace, Inc. - Common Stock (NQ:NPCE)

13.83 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Mar 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 13.83
Bid (Size) 13.88 (100)
Ask (Size) 17.50 (100)
Prev. Close 13.83
Today's Range 13.83 - 13.83
52wk Range 7.562 - 18.98
Shares Outstanding 24,296,259
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NeuroPace (NPCE) Q4 2025 Earnings Call Transcript ↗
March 03, 2026
NeuroPace (NPCE) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
NeuroPace Inc (NASDAQ:NPCE) Beats Q4 2025 Estimates and Reiterates 2026 Outlook ↗
March 03, 2026
Via Chartmill

Performance

YTD
-8.8%
-8.8%
1 Month
-13.1%
-13.1%
3 Month
-13.7%
-13.7%
6 Month
+51.3%
+51.3%
1 Year
+17.1%
+17.1%

More News

Read More
News headline image
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
March 03, 2026
From NeuroPace, Inc.
Via Business Wire
News headline image
NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026
February 20, 2026
From NeuroPace, Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
Via Benzinga
News headline image
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
January 13, 2026
From NeuroPace, Inc.
Via Business Wire
News headline image
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 31, 2025
From NeuroPace, Inc.
Via Business Wire
News headline image
NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy
December 17, 2025
From NeuroPace, Inc.
Via Business Wire
News headline image
NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy
December 08, 2025
From NeuroPace, Inc.
Via Business Wire
News headline image
NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting
December 02, 2025
From NeuroPace, Inc.
Via Business Wire
News headline image
NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services
November 24, 2025
From NeuroPace, Inc.
Via Business Wire
News headline image
NeuroPace (NPCE) Q3 2025 Earnings Call Transcript ↗
November 09, 2025
Via The Motley Fool
Topics Earnings World Trade
News headline image
These stocks are moving in today's session ↗
November 05, 2025
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
November 05, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
November 05, 2025
Via Benzinga
News headline image
Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday ↗
November 05, 2025
Via Benzinga
News headline image
Wednesday's session: gap up and gap down stocks ↗
November 05, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
November 05, 2025
Via Benzinga
News headline image
What's going on in today's after hours session ↗
November 04, 2025
Via Chartmill
News headline image
NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
November 04, 2025
From NeuroPace, Inc.
Via Business Wire
News headline image
Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
October 23, 2025
Via MarketMinute
Topics Earnings Supply Chain
News headline image
NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025
October 22, 2025
From NeuroPace, Inc.
Via Business Wire
News headline image
NeuroPace to Participate in Upcoming Healthcare Conferences
August 28, 2025
From NeuroPace, Inc.
Via Business Wire
News headline image
NeuroPace Revenue Jumps 22 Percent in Q2 ↗
August 12, 2025
Via The Motley Fool
News headline image
NeuroPace (NPCE) Q2 2025 Earnings Call Transcript ↗
August 12, 2025
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is Neuropace, Inc. - Common Stock publicly traded?
Yes, Neuropace, Inc. - Common Stock is publicly traded.
What exchange does Neuropace, Inc. - Common Stock trade on?
Neuropace, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neuropace, Inc. - Common Stock?
The ticker symbol for Neuropace, Inc. - Common Stock is NPCE on the Nasdaq Stock Market
What is the current price of Neuropace, Inc. - Common Stock?
The current price of Neuropace, Inc. - Common Stock is 13.83
When was Neuropace, Inc. - Common Stock last traded?
The last trade of Neuropace, Inc. - Common Stock was at 03/03/26 04:00 PM ET
What is the market capitalization of Neuropace, Inc. - Common Stock?
The market capitalization of Neuropace, Inc. - Common Stock is 336.02M
How many shares of Neuropace, Inc. - Common Stock are outstanding?
Neuropace, Inc. - Common Stock has 336M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap